Compare
Up to four compounds, side by side.
Useful for choosing between similar peptides or planning a stack.
Add a peptide
| Attribute | GLP-1 / Amylin Combo CagriSema |
|---|---|
| Summary | Next-gen weekly combo — additive weight loss vs semaglutide alone. |
| Mechanism | Combines weekly cagrilintide (amylin analog) with weekly semaglutide for additive appetite suppression. |
| Top outcomes |
|
| Evidence | emerging |
| Half-life | ~7 days (each component) |
| Administration | subq |
| Legal status | research only |
| Safety | Nausea additive between agents; long-term safety pending. |